US5869667A - Process for preparing 2- pyrimidinecarboxylates - Google Patents

Process for preparing 2- pyrimidinecarboxylates Download PDF

Info

Publication number
US5869667A
US5869667A US08/891,787 US89178797A US5869667A US 5869667 A US5869667 A US 5869667A US 89178797 A US89178797 A US 89178797A US 5869667 A US5869667 A US 5869667A
Authority
US
United States
Prior art keywords
process according
alkoxy
alkyl
palladium
sup
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US08/891,787
Inventor
Yves Bessard
Gerhard Stucky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lonza AG
Original Assignee
Lonza AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza AG filed Critical Lonza AG
Assigned to LONZA AG reassignment LONZA AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BESSARD, YVES, STUCKY, GERHARD
Application granted granted Critical
Publication of US5869667A publication Critical patent/US5869667A/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms

Definitions

  • the invention relates to a process for preparing substituted 2-pyrimidinecarboxylates by reacting 2-halopyrimidines with carbon monoxide and an alcohol in the presence of a catalyst and a base.
  • the esters which can be prepared according to the invention have the general formula: ##STR2## wherein: R is C 1-6 -alkyl, C 3-6 -cycloalkyl, aryl or arylalkyl, and
  • R 1 to R 3 are, independently of one another, hydrogen, C 1-6 -alkyl, fluorinated C 1-6 -alkyl, C 1-6 -alkoxy, (C 1-6 -alkoxy)-C 1-6 -alkyl or (C 1-6 -alkoxy)carbonyl.
  • An object of the invention is to provide an alternative process which proceeds from readily accessible educts and provides high yields.
  • Other objects and advantages of the invention are set out herein or are obvious herefrom to one skilled in the art.
  • the invention involves a process for preparing 2-pyrimidinecarboxylates of the general formula: ##STR3## wherein R is C 1-6 -alkyl, C 3-6 -cycloalkyl, aryl or arylalkyl, and R 1 to R 3 are, independently of one another, hydrogen, C 1-6 -alkyl, fluorinated C 1-6 -alkyl, C 1-6 -alkoxy, (C 1-6 -alkoxy)-C 1-6 -alkyl or (C 1-6 -alkoxy)carbonyl.
  • R has the above-mentioned meaning, in the presence of a base to form the desired product (I) in good yield if a palladium/phosphine complex is used as the catalyst.
  • C 1-6 -alkyl is to be understood as meaning all linear and branched primary, secondary or tertiary alkyl groups containing up to 6 carbon atoms.
  • C 1-6 -alkoxy and (C 1-6 -alkoxy)carbonyl are to be understood as meaning the ether and ester functions made up of C 1-6 -alkyl and oxygen or oxygen and carbonyl and, analogously thereto, (C 1-6 -alkoxy)-C 1-6 -alkyl is to understood as meaning the alkoxyalkyl groups formed by replacing a hydrogen atom in C 1-6 -alkyl by C 1-6 -alkoxy, for example, methoxymethyl or ethoxymethyl.
  • aryl is to be understood as meaning, in particular, monocyclic or polycyclic systems, for example, phenyl, naphthyl, biphenylyl or anthryl.
  • These cyclic systems may carry one or more identical or different substituents, for example, low alkyl groups, such as methyl, halogenated alkyl groups, such as trifluoromethyl, low alkoxy groups, such as methoxy, or low alkylthio (alkanesulfanyl) or alkanesulfonyl groups, such as methylthio or ethanesulfonyl.
  • phenyl is to be understood as meaning, in particular, groups such as fluorophenyl, methoxyphenyl, tolyl or trifluoromethylphenyl, the substituents preferably being located in the para-position.
  • arylalkyl is to be understood as meaning the groups formed from low alkyl groups, in particular C 1-6 -alkyl, by replacing a hydrogen atom by one of the aryl groups defined above.
  • the 2-halopyrimidines (II) which serve as the starting material are known compounds or can be prepared analogously to known compounds.
  • a process for preparing 2-halo-4,6-dialkoxypyrimidines is described, for example, in European Published Patent Application No. 0582288.
  • the 2-chloropyrimidines (X is Cl) are used as 2-halopyrimidines.
  • C 1-4 -alkylesters (R is C 1-4 -alkyl) prepared by the process according to the invention by using the corresponding C 1-4 -alkanol as alcohol (III), are preferred. Particularly preferred are methyl, ethyl and isopropyl esters.
  • 2-pyrimidinecarboxylates (I) which carry hydrogen, C 1-4 -alkoxy groups, (C 1-4 -alkoxy)carbonyl groups or (C 1-4 -alkoxy)methyl groups in positions 4 and 6 of the pyrimidine ring (R 1 , R 3 ).
  • a tertiary phosphine is advantageously used as the phosphine in the catalytically active palladium/phosphine complex.
  • Suitable for example, are triarylphosphines, such as triphenylphosphine or triphenylphosphines substituted on the phenyl groups, or diarylphosphines in which the third valency on the phosphorus is occupied by another organic radical, for example, an aliphatic chain or a metallocenyl system.
  • Diphosphines are preferably used which have the general formula:
  • R 4 to R 7 are, independently of one another, optionally substituted phenyl, C 1-6 -alkyl or C 3-6 -cycloalkyl and Q is a 1,1'-ferrocenediyl group or a group of the formula -- CH 2 ! n --, where n is 3 or 4.
  • the catalytically active palladium/phosphine complex is advantageously formed in situ by reacting palladium in finely divided elemental form (for example, palladium on active carbon), a Pd(II) salt (for example, the chloride or the acetate) or a suitable Pd(II) complex for example, dichlorobis(triphenylphosphine)palladium(II)! with the phosphine.
  • a Pd(II) salt for example, the chloride or the acetate
  • a suitable Pd(II) complex for example, dichlorobis(triphenylphosphine)palladium(II)! with the phosphine.
  • the palladium is preferably used in an amount of 0.02 to 2 mol percent Pd(II) or 0.5 to 5 mol percent Pd(O) (as Pd/C), in each case relative to the halogen compound (II).
  • the phosphine is advantageously used in excess (relative to Pd), preferably in an amount of 0.2 to 10 mol percent, also relative to the halogen compound (II).
  • the alcohol (III) may also simultaneously serve as a solvent.
  • an additional solvent may be used. Suitable as additional solvents are both relatively nonpolar solvents, for example, toluene or xylene, and polar solvents, for example, acetonitrile, tetrahydrofuran or N,N-dimethylacetamide.
  • a weak base selected from the group comprising the alkali or alkaline earth salts of low carboxylic acids, the alkali or alkaline earth hydrogencarbonates or the alkali or alkaline earth (di)hydrogenphosphates, is used as the base.
  • alkali acetates in particular sodium acetate and potassium acetate.
  • the reaction temperature is preferably 80° to 250° C.
  • the carbon monoxide pressure is preferably 1 to 50 bar.
  • the reaction time depends, inter alia, on the temperature, the reactivity of the compounds used and the concentration ratios and is typically in the range of a few hours. Since subsequent reactions may occur in the case of an excessively long reaction time, the reaction process is advantageously monitored with a suitable analytical method (for example, GC) and the reaction terminated after reaching the maximum product concentration.
  • a suitable analytical method for example, GC
  • the autoclave was flushed several times with carbon monoxide, then the carbon monoxide pressure was increased to 15 bar and the reaction mixture was heated for 6 hours at 180° C. bath temperature.
  • a GC analysis of the reaction mixture revealed a yield of 99 percent with a conversion of 100 percent.
  • the reaction mixture was evaporated down in vacuo and the residue chromatographed on silica gel 60 with hexane/ethyl acetate (1:1). The yield of isolated product was 1.0 g (71 percent) of colorless crystals.
  • Other data concerning the product was:

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A process for preparing 2-pyrimidinecarboxylates of the general formula: ##STR1## wherein R is C1-6 -alkyl, C3-6 -cycloalkyl, aryl or arylalkyl, and R1 to R3 are, independently of one another, hydrogen, C1-6 -alkyl, fluorinated C1-6 -alkyl, C1-6 -alkoxy, (C1-6 -alkoxy)-C1-6 -alkyl or (C1-6 -alkoxy)carbonyl. These are obtained from the corresponding 2-halopyrimidine, the corresponding alcohol ROH and carbon monoxide in the presence of a palladium/phosphine complex and a base. 2-pyrimidinecarboxylates are intermediates for preparing herbicides.

Description

BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to a process for preparing substituted 2-pyrimidinecarboxylates by reacting 2-halopyrimidines with carbon monoxide and an alcohol in the presence of a catalyst and a base. The esters which can be prepared according to the invention have the general formula: ##STR2## wherein: R is C1-6 -alkyl, C3-6 -cycloalkyl, aryl or arylalkyl, and
R1 to R3 are, independently of one another, hydrogen, C1-6 -alkyl, fluorinated C1-6 -alkyl, C1-6 -alkoxy, (C1-6 -alkoxy)-C1-6 -alkyl or (C1-6 -alkoxy)carbonyl.
2. Background Art
Compounds having the structure of formula I are intermediates for the preparation of herbicides (European Published Patent Application No. 0152286 and German Published Patent Document No. 3,836,230) or pharmaceutically active ingredients (German Published Patent Document No. 2,341,925). Known syntheses of these compounds proceed, for example, from the corresponding 2-methylpyrimidines, whose methyl group is oxidized to form the carboxyl group with potassium permanganate and is then esterified see, for example, H. Neunhoeffer and G. Werner, Liebigs Ann. Chem., (1974), 1190-1194!. The synthesis of the compounds in which R1 ═R3 =alkoxy normally proceeds from the propanediimidates obtainable from malonic dinitrile and alcohols and the monoxalate chlorides H. Eilingsfeld et al., Chem. Ber., (1968), 101, 2426-2434!.
BROAD DESCRIPTION OF THE INVENTION
An object of the invention is to provide an alternative process which proceeds from readily accessible educts and provides high yields. Other objects and advantages of the invention are set out herein or are obvious herefrom to one skilled in the art.
The objects of the invention are achieved by the process of the invention.
The invention involves a process for preparing 2-pyrimidinecarboxylates of the general formula: ##STR3## wherein R is C1-6 -alkyl, C3-6 -cycloalkyl, aryl or arylalkyl, and R1 to R3 are, independently of one another, hydrogen, C1-6 -alkyl, fluorinated C1-6 -alkyl, C1-6 -alkoxy, (C1-6 -alkoxy)-C1-6 -alkyl or (C1-6 -alkoxy)carbonyl. In the invention process, a 2-halopyrimidine of the general formula: ##STR4## wherein R1 to R3 have the above-mentioned meanings and X is chlorine or bromine, is reacted directly with carbon monoxide and an alcohol of the general formula:
R--OH                                                      III,
wherein R has the above-mentioned meaning, in the presence of a base to form the desired product (I) in good yield if a palladium/phosphine complex is used as the catalyst.
Herein, C1-6 -alkyl is to be understood as meaning all linear and branched primary, secondary or tertiary alkyl groups containing up to 6 carbon atoms. Correspondingly, C1-6 -alkoxy and (C1-6 -alkoxy)carbonyl are to be understood as meaning the ether and ester functions made up of C1-6 -alkyl and oxygen or oxygen and carbonyl and, analogously thereto, (C1-6 -alkoxy)-C1-6 -alkyl is to understood as meaning the alkoxyalkyl groups formed by replacing a hydrogen atom in C1-6 -alkyl by C1-6 -alkoxy, for example, methoxymethyl or ethoxymethyl.
Herein, aryl is to be understood as meaning, in particular, monocyclic or polycyclic systems, for example, phenyl, naphthyl, biphenylyl or anthryl. These cyclic systems may carry one or more identical or different substituents, for example, low alkyl groups, such as methyl, halogenated alkyl groups, such as trifluoromethyl, low alkoxy groups, such as methoxy, or low alkylthio (alkanesulfanyl) or alkanesulfonyl groups, such as methylthio or ethanesulfonyl. Substituted phenyl is to be understood as meaning, in particular, groups such as fluorophenyl, methoxyphenyl, tolyl or trifluoromethylphenyl, the substituents preferably being located in the para-position. Correspondingly, arylalkyl is to be understood as meaning the groups formed from low alkyl groups, in particular C1-6 -alkyl, by replacing a hydrogen atom by one of the aryl groups defined above.
DETAILED DESCRIPTION OF THE INVENTION
The 2-halopyrimidines (II) which serve as the starting material are known compounds or can be prepared analogously to known compounds. A process for preparing 2-halo-4,6-dialkoxypyrimidines is described, for example, in European Published Patent Application No. 0582288. Preferably, the 2-chloropyrimidines (X is Cl) are used as 2-halopyrimidines.
C1-4 -alkylesters (R is C1-4 -alkyl) prepared by the process according to the invention by using the corresponding C1-4 -alkanol as alcohol (III), are preferred. Particularly preferred are methyl, ethyl and isopropyl esters.
Also preferred is the preparation of 2-pyrimidinecarboxylates (I) which are unsubstituted in position 5 of the pyrimidine ring (R2 is H).
Particularly preferred is the preparation of 2-pyrimidinecarboxylates (I) which carry hydrogen, C1-4 -alkoxy groups, (C1-4 -alkoxy)carbonyl groups or (C1-4 -alkoxy)methyl groups in positions 4 and 6 of the pyrimidine ring (R1, R3).
A tertiary phosphine is advantageously used as the phosphine in the catalytically active palladium/phosphine complex. Suitable, for example, are triarylphosphines, such as triphenylphosphine or triphenylphosphines substituted on the phenyl groups, or diarylphosphines in which the third valency on the phosphorus is occupied by another organic radical, for example, an aliphatic chain or a metallocenyl system. Diphosphines are preferably used which have the general formula:
R.sup.4 R.sup.5 P--Q--PR.sup.6 R.sup.7                     IV,
wherein R4 to R7 are, independently of one another, optionally substituted phenyl, C1-6 -alkyl or C3-6 -cycloalkyl and Q is a 1,1'-ferrocenediyl group or a group of the formula -- CH2 !n --, where n is 3 or 4.
The catalytically active palladium/phosphine complex is advantageously formed in situ by reacting palladium in finely divided elemental form (for example, palladium on active carbon), a Pd(II) salt (for example, the chloride or the acetate) or a suitable Pd(II) complex for example, dichlorobis(triphenylphosphine)palladium(II)! with the phosphine. Particularly preferred are palladium(II) acetate and dichlorobis(triphenylphosphine)palladium(II). The palladium is preferably used in an amount of 0.02 to 2 mol percent Pd(II) or 0.5 to 5 mol percent Pd(O) (as Pd/C), in each case relative to the halogen compound (II). The phosphine is advantageously used in excess (relative to Pd), preferably in an amount of 0.2 to 10 mol percent, also relative to the halogen compound (II).
The alcohol (III) may also simultaneously serve as a solvent. Optionally, an additional solvent may be used. Suitable as additional solvents are both relatively nonpolar solvents, for example, toluene or xylene, and polar solvents, for example, acetonitrile, tetrahydrofuran or N,N-dimethylacetamide.
Preferably, a weak base selected from the group comprising the alkali or alkaline earth salts of low carboxylic acids, the alkali or alkaline earth hydrogencarbonates or the alkali or alkaline earth (di)hydrogenphosphates, is used as the base. Particularly preferred are alkali acetates, in particular sodium acetate and potassium acetate.
The reaction temperature is preferably 80° to 250° C. The carbon monoxide pressure is preferably 1 to 50 bar.
The reaction time depends, inter alia, on the temperature, the reactivity of the compounds used and the concentration ratios and is typically in the range of a few hours. Since subsequent reactions may occur in the case of an excessively long reaction time, the reaction process is advantageously monitored with a suitable analytical method (for example, GC) and the reaction terminated after reaching the maximum product concentration.
The following examples illustrate the performance of the process according to the invention.
EXAMPLE 1 Methyl 4,6-dimethoxy-2-pyrimidinecarboxylate
(I, R═Me, R1 ═R3 ═OMe, and R2 ═H)
3.49 g (20 mmol) of 2-chloro-4,6-dimethoxypyrimidine (prepared according to European Published Patent Application No. 0582288), 256 mg (0.6 mmol) of 1,4-bis(diphenylphosphino)butane, 28 mg (40 μmol) of dichlorobis(triphenylphosphine)palladium(II), 4.92 g (60 mmol) of sodium acetate, 1.92 g (60 mmol) of methanol and 56 ml of tetrahydrofuran were introduced into an indirectly heated (oil bath) metal autoclave. The autoclave was flushed several times with carbon monoxide, then the carbon monoxide pressure was increased to 15 bar and the reaction mixture was heated for 6 hours at 180° C. bath temperature. A GC analysis of the reaction mixture revealed a yield of 99 percent with a conversion of 100 percent. For the purpose of working-up, the reaction mixture was evaporated down in vacuo and the residue chromatographed on silica gel 60 with hexane/ethyl acetate (1:1). The yield of isolated product was 1.0 g (71 percent) of colorless crystals. Other data concerning the product was:
M.p: 129.7°-131.1° C.
1 H NMR (CDCl3) δ=6.15 (s, 1H); 4.03 (s, 6H); 4.00 (s, 3H).
MS (m/z): 198 (M+); 197; 183; 168; 139; 125; 108; 93.
EXAMPLE 2 Methyl 4,6-dimethoxy-2-pyrimidinecarboxylate
(I, R═Me, R1 ═R3 ═OMe, and R2 ═H)
The procedure was as described in Example 1, but 9.0 mg (40 μmol of palladium(II) acetate was used instead of dichlorobis(triphenylphosphine)-palladium(II) and 333 mg (0.6 mmol) of 1,1'-bis(diphenylphosphino)ferrocene was used instead of 1,4-bis(diphenylphosphino)butane. The bath temperature was 165° C. and the reaction time was 4 hours. A GC analysis of the reaction mixture revealed a yield of 92 percent with an equally large conversion. The yield of isolated product was 3.36 g (85 percent) of colorless crystals.
EXAMPLE 3 Methyl 4,6-dimethoxy-2-pyrimidinecarboxylate
(I, R═Me, R1 ═R3 ═OMe, and R2 ═H)
The procedure was as described in Example 2, but the tetrahydrofuran was replaced by methanol (total amount: 50 ml) and the reaction time was reduced to 2 hours. A GC analysis of the reaction mixture revealed a quantitative yield and conversion. The yield of isolated product was 3.54 g (90 percent) of light beige crystals.
EXAMPLE 4 Methyl 4,6-dimethoxy-2-pyrimidinecarboxylate
(I, R═Me, R1 ═R3 ═OMe, and R2 ═H)
The procedure was as described in Example 3, but the 1,1'-bis(diphenylphosphino)ferrocene was replaced by 163 mg (0.6 mmol) of triphenylphosphine. The reaction time was 4 hours at 170° C. bath temperature. A GC analysis of the reaction mixture revealed a yield of 42 percent (in addition to 58 percent of unconverted starting material).
EXAMPLE 5 Methyl 4,6-dimethoxy-2-pyrimidinecarboxylate
The procedure was as described in Example 4, but the triphenylphosphine was replaced by 211 mg (0.6 mmol) of tris(4-methyoxyphenyl)phosphine. A GC analysis of the reaction mixture revealed a yield of 62 percent (in addition to 38 percent of unconverted starting material).
EXAMPLE 6 Ethyl 4,6-dimethoxy-2-pyrimidinecarboxylate
(I, R═Et, R1 ═R3 ═OMe, and R2 ═H)
The procedure was as described in Example 3, but 50 ml of ethanol was used instead of methanol. The reaction time was 2.5 hours at 160° C. bath temperature. A GC analysis of the reaction mixture revealed a yield of 95.5 percent (in addition to 4.5 percent of unreacted starting material). The yield of isolated product was 3.71 g (86.7 percent) of pale yellow crystals, content (GC) 99.2 percent. Other data regarding the product was:
M.p.: 55.9°-57.4° C.
1 H NMR (CDCl3) δ=6.15 (s, 1H); 4.46 (q, 2H); 4.02 (s, 6H); 1.43 (t, 3H).
MS (m/z): 212 (M+); 211; 183; 154; 140; 125.
EXAMPLE 7 Propyl 4,6-dimethoxy-2-pyrimidinecarboxylate
(I, R=i-Pr, R1 ═R3 ═OMe, and R2 ═H)
The procedure was as described in Example 3, but 50 ml of isopropyl alcohol was used instead of methanol. The reaction time was 4 hours at 170° C. bath temperature. A GC analysis of the reaction mixture revealed a yield of 87 percent, with a conversion of 92 percent. The yield of isolated product was 2.46 g (54 percent) of greenish crystals, content (GC) 100 percent. Other data concerning the product was:
M.p.: 64.6°-66.6° C.
1 H NMR (CDCl3) δ=6.15 (s, 1H); 5.28 (sept., 1H); 4.01 (s, 6H); 1.42 (d, 6H).
MS (m/z): 226 (M+); 211; 183; 167; 140.
EXAMPLE 8 Cyclohexyl 4,6-dimethoxy-2-pyrimidinecarboxylate
(I, R=cyclohexyl, R1 ═R3 ═OMe, and R2 ═H)
The procedure was as described in Example 3, but the methanol was replaced by 50 ml of cyclohexanol. The reaction time was 3 hours and the bath temperature was 160° C. The yield of isolated product was 4.08 g (75 percent) of light yellow crystals. Other data regarding the product was:
M.p.: 99.0°-101.2° C.
1 H NMR (CDCl3) δ=6.15 (s, 1H); 5.07 (m, 1H); 4.01 (s, 6H); 2.0 (m, 2H); 1.8 (m, 2H); 1.6 (m, 3H); 1.4 (m, 3H).
MS (m/z): 266 (M+); 221; 185; 167; 139.
EXAMPLE 9 Benzyl 4,6-dimethoxy-2-pyrimidinecarboxylate
(I, R=benzyl, R1 ═R3 ═OMe, and R2 ═H)
The procedure was as described in Example 3, but the methanol was replaced by 4.33 g of benzyl alcohol and 50 ml of tetrahydrofuran. The reaction time was 3 hours and the bath temperature was 160° C. The yield of isolated product was 4.18 g (76 percent) of beige crystals. Other data regarding the product was:
M.p.: 96.8°-98.1° C.
1 H NMR (CDCl3) δ=7.50 ("d", 2H); 7.45 (m, 3H); 6.15 (s, 1H); 5.43 (s, 2H); 4.01 (s, 6H).
MS (m/z): 274 (M+); 246; 168; 140.

Claims (17)

What is claimed is:
1. A process for preparing a 2-pyrimidinecarboxylate of formula: ##STR5## wherein R is C1-6 -alkyl, C3-6 -cycloalkyl, aryl or arylalkyl, and R1 to R3 are, independently of one another, hydrogen, C1-6 -alkyl, fluorinated C1-6 -alkyl, C1-6 -alkoxy, (C1-6 -alkoxy)-C1-6 -alkyl or (C1-6 -alkoxy)carbonyl, comprising reacting a 2-halopyrimidine of formula: ##STR6## wherein R1 to R3 have the above-mentioned meanings and X is chlorine or bromine, with carbon monoxide and an alcohol of formula:
R--OH                                                      III,
wherein R has the above-mentioned meaning, in the presence of a catalytically active palladium/phosphine complex and a base.
2. The process according to claim 1 wherein X is chlorine.
3. The process according to claim 2 wherein R is C1-4 -alkyl.
4. The process according to claim 3 wherein R2 is hydrogen.
5. The process according to claim 4 wherein R1 and R3 are, independently of one another, hydrogen, C1-4 -alkoxy, (C1-4 -alkoxy)carbonyl or (C1-4 -alkoxy)methyl.
6. The process according to claim 5 wherein a diphosphine or formula:
R.sup.4 R.sup.5 P--Q--PR.sup.6 R.sup.7                     IV,
wherein R4 to R7 are, independently of one another, phenyl, optionally substituted phenyl, C1-6 -alkyl or C3-6 -cycloalkyl and Q is a 1,1'-ferrocenediyl group or a group of the formula -- CH2 !n --, wherein n is 3 or 4, is used as phosphine in the catalytically active palladium/phosphine complex.
7. The process according to claim 6 wherein the catalytically active palladium/phosphine complex is formed in situ from the phosphine and palladium(II) acetate or dichlorobis(triphenylphosphine)palladium(II).
8. The process according to claim 7 wherein a base selected from the group consisting of the alkali and alkaline earth salts of low carboxylic acids, the alkali and alkaline earth hydrogencarbonates and the alkali and alkaline earth (di)hydrogenphosphates, is used as the base.
9. The process according to claim 8 wherein an alkali acetate is used as the base.
10. The process according to claim 9 wherein sodium acetate or potassium acetate is used as the base.
11. The process according to claim 1 wherein R2 is hydrogen.
12. The process according to claim 1 wherein R1 and R3 are, independently of one another, hydrogen, C1-4 -alkoxy, (C1-4 -alkoxy)carbonyl or (C1-4 -alkoxy)methyl.
13. The process according to claim 1 wherein a diphosphine of the formula:
R.sup.4 R.sup.5 P--Q--PR.sup.6 R.sup.7                     IV,
wherein R4 to R7 are, independently of one another, phenyl, optionally substituted phenyl, C1-6 -alkyl or C3-6 -cycloalkyl and Q is a 1,1'-ferrocenediyl group or a group of the formula -- CH2 !n --, wherein n is 3 or 4, is used as phosphine in the catalytically active palladium/phosphine complex.
14. The process according to claim 1 wherein the catalytically active palladium/phosphine complex is formed in situ from the phosphine and palladium(II) acetate or dichlorobis(triphenylphosphine)palladium(II).
15. The process according to claim 1 wherein a base selected from the group consisting of the alkali and alkaline earth salts of low carboxylic acids, the alkali and alkaline earth hydrogencarbonates and the alkali and alkaline earth (di)hydrogenphosphates, is used as the base.
16. The process according to claim 1 wherein an alkali acetate is used as the base.
17. The process according to claim 1 wherein sodium acetate or potassium acetate is used as the base.
US08/891,787 1996-07-18 1997-07-14 Process for preparing 2- pyrimidinecarboxylates Expired - Fee Related US5869667A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH179796 1996-07-18
CH1797/96 1996-07-18

Publications (1)

Publication Number Publication Date
US5869667A true US5869667A (en) 1999-02-09

Family

ID=4218832

Family Applications (1)

Application Number Title Priority Date Filing Date
US08/891,787 Expired - Fee Related US5869667A (en) 1996-07-18 1997-07-14 Process for preparing 2- pyrimidinecarboxylates

Country Status (9)

Country Link
US (1) US5869667A (en)
EP (1) EP0819679B1 (en)
JP (1) JPH1072451A (en)
AT (1) ATE227275T1 (en)
CA (1) CA2208900C (en)
DE (1) DE59708652D1 (en)
DK (1) DK0819679T3 (en)
ES (1) ES2185842T3 (en)
PT (1) PT819679E (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090275758A1 (en) * 1999-09-27 2009-11-05 Murat Acemoglu Process for phenylacetic acid derivatives
CN118994030A (en) * 2024-08-01 2024-11-22 上海毕臣生化科技有限公司 Preparation method of pyrimidine derivative 4, 6-dichloro-2-pyrimidine carboxylic acid methyl ester

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001007415A1 (en) * 1999-07-28 2001-02-01 Lonza Ag Method of producing pyridazine-3,6-dicarboxylic acid esters
WO2001007416A1 (en) * 1999-07-28 2001-02-01 Lonza Ag Method of producing pyridazine carboxylic acid derivatives

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2341925A1 (en) * 1973-08-20 1975-03-06 Thomae Gmbh Dr K 2,4, (opt.5-), 6-substd. pyriminidines as antithrombic agents - e.g. 6-methyl-5-nitro-2-piperazino-4-thiomorpolino-pyrimidine
EP0152286A1 (en) * 1984-02-09 1985-08-21 E.I. Du Pont De Nemours And Company Herbicidal pyrazole sulfonylureas
EP0282266A2 (en) * 1987-03-12 1988-09-14 Nihon Nohyaku Co., Ltd. Process for producing carboxylic acid amides or esters
DE3826230A1 (en) * 1988-08-02 1990-02-08 Hoechst Ag HETEROCYCLIC N-ACYLSUFONAMIDES, METHOD FOR THE PRODUCTION THEREOF, THE AGENTS THEREOF AND THEIR USE AS HERBICIDES OR GROWTH REGULATORS
EP0582288A1 (en) * 1992-08-05 1994-02-09 Lonza Ag Process for the preparation of 2-halogeno-4,6-dialkoxy pyrimidines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0873403A (en) * 1994-06-30 1996-03-19 Nippon Nohyaku Co Ltd Method for producing halogen-substituted benzoic acid

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2341925A1 (en) * 1973-08-20 1975-03-06 Thomae Gmbh Dr K 2,4, (opt.5-), 6-substd. pyriminidines as antithrombic agents - e.g. 6-methyl-5-nitro-2-piperazino-4-thiomorpolino-pyrimidine
EP0152286A1 (en) * 1984-02-09 1985-08-21 E.I. Du Pont De Nemours And Company Herbicidal pyrazole sulfonylureas
EP0282266A2 (en) * 1987-03-12 1988-09-14 Nihon Nohyaku Co., Ltd. Process for producing carboxylic acid amides or esters
DE3826230A1 (en) * 1988-08-02 1990-02-08 Hoechst Ag HETEROCYCLIC N-ACYLSUFONAMIDES, METHOD FOR THE PRODUCTION THEREOF, THE AGENTS THEREOF AND THEIR USE AS HERBICIDES OR GROWTH REGULATORS
EP0582288A1 (en) * 1992-08-05 1994-02-09 Lonza Ag Process for the preparation of 2-halogeno-4,6-dialkoxy pyrimidines

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
Chemical Abstact, vol. 125, No. 3, (Jul. 15, 1996), 125:33323k. *
Eilingsfeld, H. et al., Chem. Ber., (1968), 101, 2426 2434. *
Eilingsfeld, H. et al., Chem. Ber., (1968), 101, 2426-2434.
Eilingsfeld, H., et al., Chem. Ber., (1968), 101, 2426 2434. *
Eilingsfeld, H., et al., Chem. Ber., (1968), 101, 2426-2434.
Neunhoeffer, H., and G. Werner, Liebigs Ann. Chem., (1974), 1190 1194. *
Neunhoeffer, H., and G. Werner, Liebigs Ann. Chem., (1974), 1190-1194.
Neunhoffer, H., and G. Werner, Liebigs Ann. Chem., (1974), 1190 1194. *
Neunhoffer, H., and G. Werner, Liebigs Ann. Chem., (1974), 1190-1194.

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090275758A1 (en) * 1999-09-27 2009-11-05 Murat Acemoglu Process for phenylacetic acid derivatives
US7906677B2 (en) 1999-09-27 2011-03-15 Novartis Ag Process for phenylacetic acid derivatives
CN118994030A (en) * 2024-08-01 2024-11-22 上海毕臣生化科技有限公司 Preparation method of pyrimidine derivative 4, 6-dichloro-2-pyrimidine carboxylic acid methyl ester
CN118994030B (en) * 2024-08-01 2025-09-19 上海毕臣生化科技有限公司 Preparation method of pyrimidine derivative 4, 6-dichloro-2-pyrimidine carboxylic acid methyl ester

Also Published As

Publication number Publication date
CA2208900A1 (en) 1998-01-18
DE59708652D1 (en) 2002-12-12
CA2208900C (en) 2006-08-01
DK0819679T3 (en) 2003-02-24
EP0819679A2 (en) 1998-01-21
ES2185842T3 (en) 2003-05-01
EP0819679B1 (en) 2002-11-06
PT819679E (en) 2003-03-31
JPH1072451A (en) 1998-03-17
EP0819679A3 (en) 1998-01-28
ATE227275T1 (en) 2002-11-15

Similar Documents

Publication Publication Date Title
US5821374A (en) Process for the oxidation of alcohols
US6156925A (en) Process for the preparation of halogenated phenylmaloates
DK1656351T3 (en) Process for preparing 4-aryl-nicotinamide derivatives
US4755614A (en) Preparation of herbicides containing a phosphonate group from intermediate benzoxazines
US5869667A (en) Process for preparing 2- pyrimidinecarboxylates
US6103906A (en) Process for the preparation of 2,6-pyridinedicarboxylic acid esters
US5380910A (en) Method for producing an asymmetric biaryl derivative
US7009058B1 (en) Method for preparing pyridine-2,3-dicarboxylic acid esters
US5821368A (en) Method for preparing pyrimidin-2-ylacetic acid esters
US5508425A (en) Process for producing 2-substituted 5-chlorimidazoles
US5756815A (en) Process for the preparation arylamalonates
US5852212A (en) Process for preparation of optically active α-bromo and α-chlorocarboxylic compounds
EP1002788B1 (en) Process for preparing halogenated phenylmalonates
RU2242467C2 (en) Method for preparing derivatives of thiobarbituric acid
US6570035B2 (en) Process for producing pivaloyl-acetic acid ester
US5892032A (en) Process for the preparation of arylamides of heteroaromatic carboxylic acids
US5789596A (en) Process for the preparation of 1-acyl-4-arylpiperidines
US5532386A (en) Catalytic process for eliminating carboxylic ester and acyl groups from organic compounds
US4945178A (en) Preparation of 4-carboalkoxy-1,3-cyclohexanedione type compounds
CA2473422C (en) Preparation of 5-chlorimidazoles
US4447609A (en) Method of preparing 2-alkoxy-4-aminopyrimidines
ITAYA et al. The heck reaction of N-protected vinylglycines with 4-iodoanisole
US4943675A (en) Anilinopyrimidine derivatives
EP0990639A1 (en) Process for producing n-cyclopropylanilines and intermediates used therefor
EP1440064B1 (en) Process for the preparation of (pyrimidin-2-yl)methyl ketones

Legal Events

Date Code Title Description
AS Assignment

Owner name: LONZA AG, SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BESSARD, YVES;STUCKY, GERHARD;REEL/FRAME:008686/0594

Effective date: 19970630

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20110209